|
May 27
|
Organigram Global Announces CEO Succession Plan
|
|
Apr 24
|
Organigram Global’s Products Recognized at the CNB Awards
|
|
Apr 22
|
Organigram Global Shares Recording of its OG Investor Session
|
|
Feb 12
|
OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
|
|
Feb 11
|
Organigram (OGI) Q1 2025 Earnings Call Transcript
|
|
Feb 11
|
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
|
|
Feb 11
|
OrganiGram: Fiscal Q1 Earnings Snapshot
|
|
Feb 11
|
Organigram Reports First Quarter Fiscal 2025 Results
|
|
Jan 22
|
Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains?
|
|
Dec 30
|
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts?
|
|
Aug 7
|
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
|
|
Aug 7
|
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
|
|
Aug 6
|
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
|
|
Jul 29
|
Organigram Announces Appointment of Craig Harris to Board of Directors
|
|
Jul 24
|
Update: Organigram Loses 4.7% as it Completes a Partial Third-Tranche Investment of US$1 Million in Phylos
|
|
Jul 24
|
Organigram Completes Partial Third Tranche Investment of US$1 Million in Phylos
|
|
Jul 24
|
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
|
|
Jul 23
|
US, Canadian pot firms eye Germany for growth as market stagnates at home
|
|
Jun 25
|
Organigram Invests in Sanity Group, a Leading German Cannabis Company
|
|
May 14
|
Organigram (OGI) Q2 2024 Earnings Call Transcript
|